8:30 am Registration & Networking

9:10 am Chair’s Opening Remarks

9:15 am Developing a Suite of Coarse-Grained Molecular Models for Protein Candidate Selection

  • Chris Roberts Professor - Chemical & Biomolecular Engineering, University of Delaware

9:45 am Computational Drug Discovery Through Computational Scientific Expert Identification: Data-Driven Recruiting, Organization Building, & Virtual Biotech 2.0

10:15 am Speed Networking & Morning Networking Break

11:00 am Generative Machine Learning for Design of Peptides & Peptidomimetics

  • Ho Leung Ng Associate Professor - Biochemistry & Molecular Biophysics, Kansas State University

11:30 am AI-Driven Antibody Diversity to Explore Discovery & Developability

12:00 pm Networking Roundtable Lunch

Synopsis

Make the most of your lunch break by joining an informal roundtable discussion:

Applicability of Machine Learning in Biologics Discovery & Development

1:30 pm The Many-Body Physics of Antibody Formulation

2:00 pm The Real Value & Opportunities in End-to-End Computational Drug Development for Biologics

  • Neeraj Agrawal Senior Scientist, Group Lead of Attribute Science Data Engineering , Amgen

2:30 pm Fireside Chat: A Unified Approach to Biologic Drug Design, Discovery & Development

  • Neeraj Agrawal Senior Scientist, Group Lead of Attribute Science Data Engineering , Amgen
  • Sandeep Kumar Senior Research Fellow (Biotherapeutics) & Group Leader, Boehringer Ingelheim
  • Jeremy Schmit Associate Professor, Kansas State University
  • Nicolas Angell Director - Process Development & Pre-Pivotal Attribute Sciences, Amgen

Synopsis

  • What is the future opportunity with bioinformatics?
    • From candidate screening to developability prediction to manufacturing
  • Where are we seeing traction? Modality vs antibody vs other biologics?
  • Collaboration with academia & lessons learned during COVID
  • Revolutionizing biologics drug discovery and development approach – from philosophy to practicality

3:15 pm Chair’s Closing Remarks & End of Summit

  • Nicolas Angell Director - Process Development & Pre-Pivotal Attribute Sciences, Amgen